Interactive Map: Advance market commitment for pneumococcal vaccines

This map shows the availability of pneumococcal vaccines PCV10 and PCV13 through the Advanced Market Commitment scheme designed to get life saving vaccines to the developing world as fast and reliably as possible. *Source: Advance Market Commitment for Pnewumococcal Vaccines, Annual Report 1 April 2013 – 31 March 2014, prepared by the GAVI Alliance Click here to see our Advance …

An interview with Dr Rappuoli on the vaccine industry

As part of a series of interviews conducted with leading speakers of the World Vaccine Congress in Washington D.C., Terrapinn were delighted to sit down with Dr Rino Rappuoli, Global Head of Vaccines Research at Novartis Vaccines and Diagnostics. The conversation delved into the future role of big pharma in vaccines, how to deal with anti-vaccine rhetoric and what big …

Meningitis Vaccine Project: working to eliminate epidemic meningitis in sub-Saharan Africa

Following the meningitis epidemic of 1996, African public health officials asked WHO to help them address the problem. Conjugate meningococcal vaccines were recommended following international meetings in 2000 and 2001. The Meningitis Vaccine Project was created in June 2001 to develop, test, license and implement the widespread use of conjugate meningococcal vaccines in Africa.  Dr Marc LaForce, Meningitis Vaccine Project …